Skip to Main Content

Author Details

Mitchell H Gail
1966
373
88
PMIDPaper TitleJournal TitlePublished Year
35347708Increasing efficiency and reducing bias when assessing HPV vaccination efficacy by using nontargeted HPV strains.Biometrics2023
36121028Discussion of "A formal causal interpretation of the case-crossover design" by Zach Shahn, Miguel A. Hernan, and James M. Robins.Biometrics2023
37856326Exposure to polycyclic aromatic hydrocarbons, volatile organic compounds, and tobacco-specific nitrosamines and incidence of esophageal cancer.2023
36593337Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts.Eur J Epidemiol2023
34857420Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial.Vaccine2022
36172128Behavioral factors and SARS-CoV-2 transmission heterogeneity within a household cohort in Costa Rica.Res Sq2022
36224712Accommodating population differences when validating risk prediction models.Stat Med2022
35759730Tools for Contralateral Prophylactic Mastectomy Decision Making.Journal of Clinical Oncology2022
35640980Performance of Cervical Screening a Decade Following HPV Vaccination: The Costa Rica Vaccine Trial.J Natl Cancer Inst2022
35681763Spline Analysis of Biomarker Data Pooled from Multiple Matched/Nested Case-Control Studies.Cancers2022
35929779The Oral Microbiome and Lung Cancer Risk: An Analysis of 3 Prospective Cohort Studies.J Natl Cancer Inst2022
36704711<i>fast.adonis</i>: a computationally efficient non-parametric multivariate analysis of microbiome data for large-scale studies.Bioinform Adv2022
33616159Assessing risk model calibration with missing covariates.Biostatistics2022
33270907Weight calibration to improve efficiency for estimating pure risks from the additive hazards model with the nested case-control design.Biometrics2022
32976571Power of Microbiome Beta-Diversity Analyses Based on Standard Reference Samples.Am J Epidemiol2021
33963588Thoughts on "AIDS and COVID-19: A Tale of Two Pandemics and the Role of Statisticians" by Susan S. Ellenberg and Jeffrey S. Morris.Statistics in Medicine2021
34299799Associations between Biomarkers of Exposure and Lung Cancer Risk among Exclusive Cigarette Smokers in the Golestan Cohort Study.Int J Environ Res Public Health2021
31394013Estimating the decision curve and its precision from three study designs.Biom J2020
31625599On Mendelian randomization analysis of case-control study.Biometrics2020
32297554Confidence intervals for the difference between two relative risks.Statistical Methods in Medical Research2020
31830235The Need for Combined Assessment of Multiple Outcomes in Noninferiority Trials in Oncology.JAMA Oncology2020
31556449Choosing Breast Cancer Risk Models: Importance of Independent Validation.Journal of the National Cancer Institute2020
32091596Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Trial.J Natl Cancer Inst2020
32091594Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial.J Natl Cancer Inst2020
31863593Weight calibration to improve the efficiency of pure risk estimates from case-control samples nested in a cohort.Biometrics2020
33271093Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial.Lancet Oncol2020
32552454Robustness of risk-based allocation of resources for disease prevention.Statistical Methods in Medical Research2020
31165158Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification.J Natl Cancer Inst2020
31515292Perspectives for Consideration in the Development of Microbial Cell Reference Materials.Cancer Epidemiology Biomarkers and Prevention2019
31579814Heart Transplantation From Hepatitis C-Positive Donors in the Era of Direct Acting Antiviral Therapy: A Comprehensive Literature Review.Transplantation Direct2019
31822541Design choices for observational studies of the effect of exposure on disease incidence.BMJ Open2019
32337492Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199).JNCI Cancer Spectr2019
29912394Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts.J Natl Cancer Inst2019
30569596Design and analysis considerations for combining data from multiple biomarker studies.Stat Med2019
29124779Prenatal diethylstilbestrol exposure and cancer risk in women.Environ Mol Mutagen2019
29145780Power and sample size for multivariate logistic modeling of unmatched case-control studies.Stat Methods Med Res2019
31511230Effects of <i>Helicobacter pylori</i> treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial.BMJ2019
31162092Performance of BCRAT in high-risk patients with breast cancer.Lancet Oncology, The2019
31067262Mammographic breast density and its association with urinary estrogens and the fecal microbiota in postmenopausal women.PLoS One2019
29366703Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies.Vaccine2018
28954299Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial.J Natl Cancer Inst2018
30073448Circulating 25-hydroxyvitamin D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival.European Journal of Epidemiology2018
30216148Excess Deaths Associated With Underweight, Overweight, and Obesity: An Evaluation of Potential Bias.Vital &amp; health statistics. Series 3, Analytical and epidemiological studies / [U.S. Dept. of Health and Human Services, Public Health Service, National Center for Health Statistics]2018
30068516Proportion of U.S. Trends in Breast Cancer Incidence Attributable to Long-term Changes in Risk Factor Distributions.Cancer Epidemiol Biomarkers Prev2018
30477563Next steps in studying the human microbiome and health in prospective studies, Bethesda, MD, May 16-17, 2017.Microbiome2018
29490057Breast Cancer Risk Model Requirements for Counseling, Prevention, and Screening.J Natl Cancer Inst2018
29668831Using standard microbiome reference groups to simplify beta-diversity analyses and facilitate independent validation.Bioinformatics2018
29617851Effects of Nutrition Intervention on Total and Cancer Mortality: 25-Year Post-trial Follow-up of the 5.25-Year Linxian Nutrition Intervention Trial.J Natl Cancer Inst2018
29474934Design and statistical considerations for studies evaluating the efficacy of a single dose of the human papillomavirus (HPV) vaccine.Contemporary Clinical Trials2018
27770008Evaluation of Buccal Cell Samples for Studies of Oral Microbiota.Cancer Epidemiol Biomarkers Prev2017
  • 1 - 50 of 373

Recommended Authors

Collaborators

National Cancer Institute.
Co-authored papers 41
Co-authored papers 20
National Cancer Institute
Co-authored papers 18
National Cancer Institute
Co-authored papers 17
National Cancer Institute, 9609 Medical Center Drive
Co-authored papers 15
Vanderbilt University Medical Center
Co-authored papers 14
Co-authored papers 13
National Cancer Institute, National Institutes of Health
Co-authored papers 12
Co-authored papers 10
National Cancer Institute, National Institutes of Health
Co-authored papers 9
Co-authored papers 9
National Cancer Institute
Co-authored papers 8
National Cancer Institute
Co-authored papers 8
Co-authored papers 7
David Geffen School of Medicine at university of california los angeles
Co-authored papers 7
National Cancer Institute
Co-authored papers 6
Co-authored papers 6
Co-authored papers 6
Tianjin First Central Hospital, Nankai University
Co-authored papers 5
Co-authored papers 5
National Cancer Institute
Co-authored papers 5
Co-authored papers 5
Frederick National Laboratory for Cancer Research
Co-authored papers 5
Co-authored papers 4
National Cancer Institute, National Institutes of Health, Inc.
Co-authored papers 4
National Cancer Institute
Co-authored papers 4
Co-authored papers 4
Mayo Clinic
Co-authored papers 4
Co-authored papers 4
Fred Hutchinson Cancer Center
Co-authored papers 4